Symptomatic Bradycardia Due to Alectinib in a Patient with Advanced Stage of NSCLC

Alectinib is one of the targeted therapies commonly given to patients with advanced non-small cell lung cancer (NSCLC) with mutations in the ALK gene. The most common adverse effects of alectinib are fatigue, constipation, edema, myalgia and anemia. Meanwhile, bradycardia was reported as a very comm...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Ceva Wicaksono Pitoyo (Dahkki), Cleopas Martin Rumende (Dahkki), Anindita Kartika Wiraputri (Dahkki), Fatira Ratri Audita (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Interna Publishing, 2022-04-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis